News

Rockefeller scientists found that breast and lung tumors can utilize a signaling pathway used by neurons to metastasize. These cancer cells enlist nearby blood vessels to gain access to the nerve signal, enabling their escape from the primary tumor and into the bloodstream.

Young researchers with an advanced degree can apply for the highly prestigious Eppendorf Award for Young European Investigators that acknowledges outstanding contributions to biomedical research in Europe .

Researchers have shown that Cisplatin induces senescence of peripheral neurons through overexpression of the p21 protein, which would explain the neuropathy associated with this treatment.

Aurora-A kinase is a protein that causes extensive damage to cells of the body and is known to trigger the development of leukemias and many pediatric cancers, such as neuroblastoma. Researchers at the universities of Würzburg and Frankfurt have now developed a drug that can disarm Aurora.

Scientists have demonstrated that by blocking the construction of nuclear pore complexes it was possible to shrink aggressive tumors in mice whilst leaving normal cells unaffected.

A new precision drug which stops cancer from repairing its DNA has shown promise in an early-stage clinical trial – highlighting the potential of a new class of drugs known as ATR inhibitors.

Scientists seek insight into what makes its cells tick. Caltech researchers have shown that a framework they developed, using a specialized type of microscopy, enables them to probe the metabolic processes inside cancer cells.

The University of New Hampshire is set to receive $1.8 million from the National Institutes of Health. This will be used to further the university's research to better understand drug interactions at the cellular level and help develop new targeted drugs to treat disorders including diabetes and cancer.

New research from Aarhus University shows that a circular RNA molecule, which has been designated as carcinogenic, is actually not found in the cancer cells. Researchers suggest that the molecule contributes to the development of cancer through what is known as the microenvironment.

Toronto scientists have mapped the genes allowing cancer cells to avoid getting killed by the immune system that paves the way for the development of immunotherapies that would be effective for larger patient populations and across different tumour types.